Motrin Infantsibuprofen

According to the FDA label: Uses temporarily relieves minor aches and pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever

212,475 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Motrin Infants in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Motrin Infants adverse event reports by reporter sex
SexReports
Female125,254
Male66,764
Unknown687

By Age Group

View age group data as a table
Motrin Infants adverse event reports by reporter age group
Age groupReports
0-1714,004
18-3423,666
35-4934,609
50-6440,356
65-7419,856
75+13,151

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Motrin Infants. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Motrin Infants adverse event reports by reported outcome
OutcomeReports
Other Serious99,531
Hospitalization74,301
Non-Serious60,443
Death16,642
Life-Threatening13,202
Disability9,592

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Motrin Infants. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Motrin Infants adverse event reports by year
YearReports
19981
20012
20022
20035
20041,979
20052,562
20062,554
20072,473
20082,180
20093,224
20104,735
20116,656
20128,228
20137,726
20147,341
201510,376
201613,936
201712,718
201816,871
201917,782
202016,339
202115,964
202215,252
202314,209
202413,134
202513,139
2026 (partial)3,087

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Motrin Infants

In FDA adverse event reports that mention Motrin Infants, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026